RS130-180 is a beta-arrestin-biased agonist that selectively targets the 5-hydroxytryptamine 2A receptor (5-HT2aR). It shows promise for research in neuropsychiatric disorders such as depression.
Target:
5-HT Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
